Protective Immunity and Safety of a Genetically Modified Influenza Virus Vaccine
Open Access
- 13 June 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (6) , e98685
Abstract
Recombinant influenza viruses are promising viral platforms to be used as antigen delivery vectors. To this aim, one of the most promising approaches consists of generating recombinant viruses harboring partially truncated neuraminidase (NA) segments. To date, all studies have pointed to safety and usefulness of this viral platform. However, some aspects of the inflammatory and immune responses triggered by those recombinant viruses and their safety to immunocompromised hosts remained to be elucidated. In the present study, we generated a recombinant influenza virus harboring a truncated NA segment (vNA-Δ) and evaluated the innate and inflammatory responses and the safety of this recombinant virus in wild type or knock-out (KO) mice with impaired innate (Myd88 -/-) or acquired (RAG -/-) immune responses. Infection using truncated neuraminidase influenza virus was harmless regarding lung and systemic inflammatory response in wild type mice and was highly attenuated in KO mice. We also demonstrated that vNA-Δ infection does not induce unbalanced cytokine production that strongly contributes to lung damage in infected mice. In addition, the recombinant influenza virus was able to trigger both local and systemic virus-specific humoral and CD8+ T cellular immune responses which protected immunized mice against the challenge with a lethal dose of homologous A/PR8/34 influenza virus. Taken together, our findings suggest and reinforce the safety of using NA deleted influenza viruses as antigen delivery vectors against human or veterinary pathogens.Keywords
This publication has 52 references indexed in Scilit:
- Differential Host Response, Rather Than Early Viral Replication Efficiency, Correlates with Pathogenicity Caused by Influenza VirusesPLOS ONE, 2013
- Complement C5 Activation during Influenza A Infection in Mice Contributes to Neutrophil Recruitment and Lung InjuryPLOS ONE, 2013
- Contribution of neutrophil‐derived myeloperoxidase in the early phase of fulminant acute respiratory distress syndrome induced by influenza virus infectionMicrobiology and Immunology, 2011
- Viral vectors as vaccine platforms: deployment in sightCurrent Opinion in Immunology, 2011
- Innate immune responses to influenza A H5N1: friend or foe?Trends in Immunology, 2009
- Sonic hedgehog signalling in T-cell development and activationNature Reviews Immunology, 2007
- Evidence for Phagocytosis of Influenza Virus-Infected, Apoptotic Cells by Neutrophils and Macrophages in MiceThe Journal of Immunology, 2007
- Recombinant viruses as tools to induce protective cellular immunity against infectious diseases.2004
- Expression of a foreign gene by stable recombinant influenza viruses harboring a dicistronic genomic segment with an internal promoterVirology, 2003
- Prevention of influenza-induced lung injury in mice overexpressing extracellular superoxide dismutaseAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2001